AREG-expressing ST2+ Tregs and ILC2s may also exert a tissue protective effect in immune-mediated hepatitis as it was shown for Tregs in muscle repair (41) and viral infection (42) as well as for ILC2s in biliary atresia (43), lung infection (6) and intestinal inflammation (8). This evidence concerns the gene IL1RL1 and viral infectious disease.